SCHEMBL8767323

SCHEMBL8767323

CC(C)(C)CN(CC(C)(C)C)c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.50
CYP2C19 P33261 2/20 0.43
ESR1 P03372 1/20 0.43
CYP2D6 P10635 1/20 0.42
MEN1 O00255 5/20 0.41
KMT2A Q03164 5/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C9 P11712 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
CNR2 P34972 1/20 0.41
CTSK P43235 2/20 0.38
RAB9A P51151 2/20 0.37
NPC1 O15118 1/20 0.37
NOX1 Q9Y5S8 1/20 0.37
ALDH1A1 P00352 3/20 0.37
GAA P10253 1/20 0.36
MAPT P10636 1/20 0.36
HPGD P15428 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
HTT P42858 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30353885 0.81 CYP2D6 (0.43) TSHRCYP2C19ESR1CYP2D6MEN1
SCHEMBL13259855 0.80 ESR1 (0.43) TSHRCYP2C19ESR1MEN1KMT2A
SCHEMBL10159871 0.78 CA12 (0.44) TSHRCYP2C19ESR1MEN1KMT2A
SCHEMBL8768366 0.78 CYP2C19 (0.52) TSHRCYP2C19CNR2ALDH1A1
SCHEMBL13673204 0.76 KDM4E (0.42) ESR1CNR2ALDH1A1GAAMAPT
SCHEMBL10504615 0.75 NR1H2 (0.50) TSHRALDH1A1NR1H2NR1H3
SCHEMBL17700722 0.73 TSHR (0.58) TSHRCYP2C19CYP2D6KMT2ASMN1; SMN2
SCHEMBL13673209 0.73 CA1 (0.46) SMN1; SMN2CNR2RAB9ANPC1NOX1
SCHEMBL22680830 0.72 TSHR (0.52) TSHRCYP2C19MEN1KMT2ACYP3A4
SCHEMBL16978963 0.72 APP (0.50) MEN1KMT2AALDH1A1GAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5420356-A Process for producing cyclobutanones SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1995-05-30 US claimed
US-7608619-B2 Substituted oxazole compounds with analgesic activity GRUENENTHAL GMBH (DE) 2009-10-27 US disclosed
US-7608619-B2 Substituted oxazole compounds with analgesic activity GRUENENTHAL GMBH (DE) 2009-10-27 US disclosed
US-20090069330-A1 Substituted Oxazole Compounds with Analgesic Activity GRUENENTHAL GMBH (DE) 2009-03-12 US disclosed
US-20090069330-A1 Substituted Oxazole Compounds with Analgesic Activity GRUENENTHAL GMBH (DE) 2009-03-12 US disclosed
EP-0638537-B1 Process for producing cyclobutanones SUMITOMO CHEMICAL CO (JP) 1997-08-13 EP disclosed
US-5420356-A Process for producing cyclobutanones SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1995-05-30 US disclosed
EP-0638537-A1 Process for producing cyclobutanones SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1995-02-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090069330-A1 Substituted Oxazole Compounds with Analgesic Activity OPRK1, OPRD1, OPRM1 TSHR 4202/4885CYP2C19 13/4885ESR1 1233/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.